Viasys gains FDA nod for sleep apnoea therapy:

Viasys Healthcare has gained US FDA 510(k) clearance for its ORION CPAP (continuous positive airway pressure) system for treating patients with obstructive sleep apnoea. The condition affects around 12 million individuals in the US with more than 10 million of these undiagnosed, is due to an abnormal loss of tone in the muscles of the tongue, throat and larynx during sleep, temporarily blocking airflow, said the Conshohocken, Pennsylvania firm. The ORION CPAP system targets a sleep apnoea treatment market that is growing at a rate of 20% per year.